key: cord-0868585-g3d9ry7d
authors: Iadarola, S.; Siegel, J.; Gao, Q.; McGrath, K.; Bonuck, K.
title: COVID 19 Vaccine Perceptions in the New York State Intellectual and Developmental Disabilities Community
date: 2021-03-22
journal: nan
DOI: 10.1101/2021.03.19.21253425
sha: 555bbb8495937dc02936aaaf679087979827e9b5
doc_id: 868585
cord_uid: g3d9ry7d

Background: People with intellectual and developmental disabilities (IDD) are at disproportionate risk for severe COVID 19 outcomes, particularly those living in congregate care settings. Yet, there is limited data on vaccine perceptions in the disability community. Objective: To explore COVID 19 vaccine perceptions in individuals with IDD, their family members, and those who work with them, to inform a statewide vaccine information and messaging project. Methods: A national survey, adapted for the IDD community, was distributed to a convenience sample of IDD organizations throughout New York State, in five languages. Constructs included vaccine intention, reasons for vaccine hesitancy, and trusted sources of vaccine information. Zip code data were used to map respondent location and vaccine preferences. Results: Of n= 825 respondents, approximately 75% intended to or had received the vaccine, across roles (i.e., people with disabilities, family members, direct care workers) and racial/ethnic groups. Greater vaccine hesitancy was reported in younger individuals and those making decisions on behalf of a person with IDD. Concerns included side effects and the swiftness of vaccine development. Black and Hispanic participants had heightened concerns about being an experiment for the vaccine. Trusted sources of information included healthcare providers and family members. Respondents who intended/got the vaccine were distributed throughout the state. Conclusions: Vaccine preferences in this New York State disability community sample align with national data. Identified concerns suggest the need for community education that addresses misperceptions. Age and race differences in perspectives highlight the need for tailored education, delivered by trusted messengers.

In NYS, persons with IDD living in congregate care settings experience more severe COVID-19 outcomes, along with higher case-fatality, and mortality rates 9 , in a similar pattern to that throughout the United States 10 . Staff working in NYS congregate care settings became eligible in Phase 1a, while persons with IDD including Down syndrome became eligible in Phase 1a and 1b 11 . However, across the people with IDD have not been similarly prioritized 12 . As vaccine access expands to general and IDD populations, vaccine hesitancy may be a barrier to population-level immunity. National data suggests that approximately 25-30% of adults are hesitant to receive the COVID-19 vaccine, even if it were available for free 13, 14 Congregate care staff are especially hesitant; one state-wide survey indicated that only 45% of nursing home staff were willing to take an approved COVID-19 vaccine when it became available 15 .

Promoting vaccine uptake begins with understanding the reasons for vaccine hesitancy. For COVID-19 such reasons include: concerns about side effects, lack of trust given how quickly it was developed, doubts about the vaccine's efficacy, and beliefs that COVID-19 symptoms are primarily mild 13, 16, 17 . Historical mistrust in and misconceptions of vaccines within communities of color has been observed, with less intent to get vaccinated in Black survey respondents 18 . This may be related to Black and Hispanic Americans lacking confidence that the vaccines were adequately tested in their racial and ethnic groups 19 . Such concerns understandably stem from systematic mistreatment of people of color, but can perpetuate disproportionately severe COVID-19 outcomes within African American/ Black and Hispanic/ Latino communities. Vaccine hesitancy in these communities intersects with the fact that a high percentage of congregate care workers are people of color 20 . A similar 'intersectionality' is seen among parents of color who have children with autism, as they express more vaccine hesitancy (unrelated to , compared to white parents 21 .

Community-focused interventions can increase vaccination uptake 22 , particularly when: informed by community-specific concerns; targeted toward those who are or are at risk of vaccine hesitancy, and culturally responsive. Additional considerations for people with IDD include ensuring adequate communication around health decisions, inclusion in conversations with providers and through written . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint information 23 . Preliminary data suggest that, with the authorization of multiple vaccines, there is increased vaccine confidence in communities that have historic hesitancy 17 , thus outreach and culturally sensitive education around the COVID-19 vaccine is needed in the high risk IDD population.

There is limited data on COVID-19 vaccine perceptions in the IDD community. Though a recent study reports on trust in health information among persons with disabilities 24 , to our knowledge, no data exist on the IDD community's COVID-19 vaccine preferences and reasons for them. To inform a statewide effort in NYS that is responsive to community needs and concerns, we conducted a survey of vaccine perceptions in individuals with IDD, their family members (including those who may make decisions on their behalf), and those who work with people with IDD. The aims of the survey were to characterize 1) intent to receive the COVID-19 vaccine; 2) reasons for vaccine hesitancy; and 3) trusted sources of information about the vaccine. agencies providing services to children and youth with special health care needs, and Special Olympics New York. Organizations serving persons with IDD who are Hispanic/Latino, Chinese, Korean, and South Asian also distributed the survey. Local and statewide recruitment also occurred through community partner organizations, including school districts, specialty medical clinics, centers on . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Survey Items: A full version of the survey is included in an Appendix.

Role: As noted above, respondents could occupy any of three roles with respect to disability: 1) person with IDD; 2) person who spends time with people with IDD (e.g., family); and/or 3) person who works with people with IDD.

Vaccine Intent: Intention to receive the COVID-19 vaccine was assessed with the following KFF item: "How likely would you be to get the COVID vaccine if it were offered to you for free?" We combined responses of 'definitely get,' 'probably get,' and 'already got the vaccine' into an 'Intend/ Got' category. Responses of 'probably not get,' definitely not get,' and 'don't know' were categorized as 'Do Not Intend/DK.' Through branching logic, those who fell within this latter group, alternatively referred to as "Hesitant," encountered additional questions related to reasons for hesitancy.

Reasons for Hesitancy: 'Hesitant' respondents were asked to rate nine possible reasons for hesitancy as one of the following: a 'major reason,' a 'minor reason,' 'not a reason' or a designation of "unsure/ don't know."

Branching logic guided respondents who indicated a role of 'spend time with people with disabilities' and who make medical decisions for a person with a disability to report on Vaccine Intent and Reasons for Hesitancy regarding that person with IDD. The items and response options were otherwise identical.

For respondents who provided their zip codes, we used ArcGIS to create maps of where respondents were from, and vaccine preferences by county.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint Analysis: Descriptive statistics were shown as count and percentage for demographics and each item in the survey. Odds ratios and 95% confidence intervals for respondents in the 'Intend/Got' group are compared for participants 50+ years old versus 18-49 years old were shown by race. Chi square or Fisher's exact test was used to test the difference of proportion across roles or race/ethnicity groups. To examine whether the proportion of participants with vaccine preference for self is different from those with vaccine preference for others, McNemar test was used. 

Complete surveys were received from n= 825 individuals, most of whom (85%) spent time with (e.g., family) and/or worked with persons with disabilities (PWD; see Table 1 In terms of vaccine preference, 62% of respondents would definitely or probably get a COVID-19

vaccine. Further, 13.9% of respondents had already gotten the vaccine-a rate similar to the 13.4% rate for the US adult population at the mid-point of the survey period. 26 This pattern is similar to that of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. There were no significant differences in report of 'Intend/Got' by respondent role (p= 0.28; see Table 2 ). There were, however, significant differences between preferences for oneself versus for others for whom the respondent makes health decisions (75% vs. 68%; p<.001), as shown in Table 3 . Regarding vaccine preferences by race and age ( Reasons for vaccine concern (major or minor) by race among respondents in the 'Do Not

Intend/DK' group are shown in Table 5 . Concerns about being 'Used as an Experiment' differed by . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint race/ethnicity (p<.05) with Hispanic and Black respondents reporting this more often (96% and 91%, respectively) than White or Asian respondents (76% and 67%, respectively). 'Lack of Trust in Government' also differed by race (p<.00) with higher rates reported by Black (96%) respondents compared with Hispanic (80%), White (78%), and Asian (0%) respondents. There were no racial/ethnic differences for the remaining seven potential reasons.

In the context of COVID-related health disparities in New York State, we conducted a statewide survey on COVID vaccine perceptions among people within the IDD community, including individuals with IDD, their family members, and those directly working with people with IDD. Respondents comprised a diverse sample based on race, ethnicity, age, and language. Approximately 25% of respondents reported hesitancy to receive the vaccine themselves, and about 20% indicated hesitancy to encourage a person with IDD to receive the vaccine. These rates are lower than general population surveys conducted during the same time period 17 . Intention to receive a vaccine did not differ by role, suggesting that materials to increase vaccine confidence could be relevant to all of these groups. In contrast to previous findings, vaccine hesitancy did not differ by race, ethnicity, or primary language.

There were notable age-related differences, such that older individuals had more intention to receive the vaccine. There was an interaction effect of age and race, indicating that older Black and White individuals were more likely to have vaccine intention compared to younger Black and White respondents.

The top reasons for hesitancy in our sample--concerns about side effects, concerns that the vaccine was too newly developed, not wanting to feel like an "experiment" for the vaccine, lack of overall trust in the government-are comparable to prior surveys 17 In contrast to other surveys, we included an item regarding vaccines not having been tested in PWD and found that nearly one in ten respondents cited this as a concern. While there were no group differences in many of the expressed concerns, Black and Hispanic participants had more concerns about being used as an "experiment," and Black participants . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. expressed lower trust in the government as compared to other racial/ethnic groups. The addition the "experiment" item was based upon community feedback, as well as previous literature on mistrust of the medical system within communities of color 27 . Ultimately, feeling like an experiment was one of the primary contributors to vaccine hesitancy, which highlights critical opportunities for addressing this concern through community educational campaigns. It will be important to empathize with concerns, particularly in the context of historical and systemic biases, and then provide evidence-based information to help address misconceptions about the vaccine. Despite the presence of mistrust in medical systems, this may not be an insurmountable barrier 28 and utilization of trusted community messengers may increase access to vaccine knowledge.

Effective vaccine confidence campaigns for people with IDD should include addressing logistical barriers, in addition to hesitancy. In exploring needed supports to receive the vaccine, people with IDD indicated that assistance setting up the appointment and understanding the process would be most helpful.

Existing materials from NYS related to the COVID-19 vaccine process are lengthy, have a high reading level, and do not include plain language versions; as such, this is a significant opportunity for those engaged in vaccine confidence efforts. Of note, over half of individuals with IDD indicated that they did not require any support. This project has several strengths. First, survey items were adapted from a previously vetted survey (i.e., from Kaiser Family Foundation), which allowed for comparison with national data. Second, to our knowledge, there is limited data on vaccine preferences and barriers in the IDD community. Third, and related to the prior strength, was the inclusion of disability specific items, including vaccine preferences for respondents who make decisions for a person with a disability. Fourth, was the project's linguistic diversity, as the survey was translated into four languages and distributed through organizations serving these language users. (The survey was translated into Bengali, but no responses received for this version.)

Fifth, the project demonstrates the utility of geospatial analysis for identifying locales to target for vaccine . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint uptake. Finally, the survey distribution process served as a means of engaging a broad, statewide network of community partners, who may be excluded from traditional recruitment efforts.

The project also had several limitations. First, as a convenience sample, findings may not be representative of New York's disability community by diagnosis or living situation. However, results may reflect biases in who chose to respond. Second, the survey items did not include specifiers for disability category or workplace setting (e.g., residential versus community). Comparisons across these subgroups may have yielded interesting findings, and future work on vaccine perceptions within the disability community should consider including these identifiers. Third, as the survey did not specify a definition of support, it is unclear if respondents who indicated that that did not need support were familiar with actual methods of obtaining an appointment, (e.g., computer registration or telephone access) and then traveling alone to a designated and possibly unfamiliar vaccine site. Fourth, data were analyzed descriptively, rather than through predictive models. The survey was developed primarily to inform messaging for community vaccine confidence campaigns; as such, we did not have a priori hypotheses or specific research questions identified. However, group differences emerged from the dataset suggest that more rigorous evaluation of characteristics that influence vaccine hesitancy would be warranted. Finally, findings were based solely upon self-report of intention to receive the COVID-19 vaccine and are not necessarily indicative of actual vaccination behavior. In addition, many of the fears expressed were specific to the COVID-19 vaccine (e.g., rapidity of vaccine development, side effects), which may not be predictive of overall vaccine hesitancy.

Understanding community perceptions of the COVID-19 vaccine is critical to providing equitable vaccine education that adequately addresses concerns and misconceptions. Statewide data suggest that, in New York, all members of the disability community would benefit from educational materials that address concerns about vaccine development and side effects. Group . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint differences based on age and race/ethnicity indicate the value of tailoring materials and of using trusted community messengers. While the presented data and trends are individual to New York State, the survey process and items can provide a template for similar evaluations in communities for whom vaccine hesitancy is a concern.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted March 22, 2021. ; https://doi.org/10.1101/2021.03.19.21253425 doi: medRxiv preprint

Are black and Hispanic persons disproportionately affected by COVID-19 because of higher obesity rates?

The association of race and COVID-19 mortality

Eunice Kennedy Shriver National Institute of Child Health and Human Development. A to Z Fact Sheets: Intellectual and Developmental Disabilities (IDDs)

In-Home and Residential Long-Term Supports and Services for Persons with Intellectual or Developmental Disabilities:Status and Trends

Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis

Risk Factors for Covid-19Mortality among Privately Insured Patients: Claims Data Analysis

The Devastating Impact of Covid-19 on Individuals with Intellectual Disabilities in the United States

State Reporting of Cases and Deaths Due to COVID-19 in Long-Term Care Facilities

COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State

COVID-19 outcomes among people with intellectual and developmental disability in California: The importance of type of residence and skilled nursing care needs

Prioritizing COVID-19 vaccinations for individuals with intellectual and developmental disabilities

KFF COVID-19 Vaccine Monitor

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine

Willingness of Long-Term Care Staff to Receive a COVID-19 Vaccine: A Single State Survey

Vaccine hesitancy: the next challenge in the fight against COVID-19

KFF COVID-19 Vaccine Monitor

Vaccination Hesitancy in the United States: A Rapid National Assessment

KFF COVID-19 Vaccine Monitor

Acknowledgments: Thank you to those who assisted with survey translation, including Yali Pang,